Cargando…

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

OBJECTIVES: To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude prostate cancer (PCa) progression during monitoring patients on active surveillance (AS). METHODS: One hundred forty-seven consecutive patients on AS with mp-MRI (T2WI, DWI, DCE-MRI) at 3T were initially enr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullrich, T., Arsov, C., Quentin, M., Mones, F., Westphalen, A. C., Mally, D., Hiester, A., Albers, P., Antoch, G., Schimmöller, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Urogenital
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553894/ https://www.ncbi.nlm.nih.gov/pubmed/32591887 http://dx.doi.org/10.1007/s00330-020-06997-1

Ejemplares similares

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
por: Klingebiel, M, et al.
Publicado: (2022)

Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy
por: Hansen, Nienke L., et al.
Publicado: (2016)

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
por: Huebner, Nicolai Alexander, et al.
Publicado: (2020)

The primacy of multiparametric MRI in men with suspected prostate cancer
por: Richenberg, Jonathan, et al.
Publicado: (2019)

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
por: Quentin, M., et al.
Publicado: (2022)

Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer
por: Wildeboer, Rogier R., et al.
Publicado: (2016)

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

3D T2-weighted imaging to shorten multiparametric prostate MRI protocols
por: Polanec, Stephan H., et al.
Publicado: (2017)

mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging
por: Gatti, Marco, et al.
Publicado: (2022)

Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics
por: Wildeboer, Rogier R., et al.
Publicado: (2019)

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
por: Wallström, Jonas, et al.
Publicado: (2021)

Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients
por: Alessi, Sarah, et al.
Publicado: (2019)

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
por: Bernatz, Simon, et al.
Publicado: (2020)

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
por: Valentin, B., et al.
Publicado: (2021)

Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
por: Beheshti, Mohsen, et al.
Publicado: (2022)

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
por: Caglic, Iztok, et al.
Publicado: (2020)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging
por: Penzkofer, Tobias, et al.
Publicado: (2021)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2021)

Accuracy of fractal analysis and PI-RADS assessment of prostate magnetic resonance imaging for prediction of cancer grade groups: a clinical validation study
por: Michallek, Florian, et al.
Publicado: (2021)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI
por: Barrett, Tristan, et al.
Publicado: (2017)

ESUR prostate MR guidelines 2012
por: Barentsz, Jelle O., et al.
Publicado: (2012)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population
por: Barrett, Tristan, et al.
Publicado: (2017)

Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection
por: Ziayee, Farid, et al.
Publicado: (2021)

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011)

Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment
por: Schelb, Patrick, et al.
Publicado: (2020)

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study
por: Sahin, Hilal, et al.
Publicado: (2021)

Feasibility of a 2(nd) generation MR-compatible manipulator for transrectal prostate biopsy guidance
por: Bomers, J. G. R., et al.
Publicado: (2016)

Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
por: Giganti, Francesco, et al.
Publicado: (2022)

Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension
por: Caglic, Iztok, et al.
Publicado: (2019)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study
por: Michallek, Florian, et al.
Publicado: (2021)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

Dual-energy CT kidney stone characterization—can diagnostic accuracy be achieved at low radiation dose?
por: Euler, André, et al.
Publicado: (2023)

MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences
por: Bura, Vlad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9vt4f07b5k3cfigea7m8b5hlq